Global Metabolic Disorders Treatment Market Research Report 2024

Report ID: 1897758 | Published Date: Sep 2024 | No. of Page: 85 | Base Year: 2023 | Rating: 3.8 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Metabolic Disorders Treatment Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Glycogen Metabolism Disease Drug
        1.2.3 Lipid Metabolism Disease Drug
        1.2.4 Amino Acid Metabolism Drug
        1.2.5 Other
    1.3 Market by Application
        1.3.1 Global Metabolic Disorders Treatment Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Hospital
        1.3.3 Retail Pharmacy
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Metabolic Disorders Treatment Market Perspective (2017-2028)
    2.2 Metabolic Disorders Treatment Growth Trends by Region
        2.2.1 Metabolic Disorders Treatment Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Metabolic Disorders Treatment Historic Market Size by Region (2017-2022)
        2.2.3 Metabolic Disorders Treatment Forecasted Market Size by Region (2023-2028)
    2.3 Metabolic Disorders Treatment Market Dynamics
        2.3.1 Metabolic Disorders Treatment Industry Trends
        2.3.2 Metabolic Disorders Treatment Market Drivers
        2.3.3 Metabolic Disorders Treatment Market Challenges
        2.3.4 Metabolic Disorders Treatment Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Metabolic Disorders Treatment Players by Revenue
        3.1.1 Global Top Metabolic Disorders Treatment Players by Revenue (2017-2022)
        3.1.2 Global Metabolic Disorders Treatment Revenue Market Share by Players (2017-2022)
    3.2 Global Metabolic Disorders Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Metabolic Disorders Treatment Revenue
    3.4 Global Metabolic Disorders Treatment Market Concentration Ratio
        3.4.1 Global Metabolic Disorders Treatment Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Metabolic Disorders Treatment Revenue in 2021
    3.5 Metabolic Disorders Treatment Key Players Head office and Area Served
    3.6 Key Players Metabolic Disorders Treatment Product Solution and Service
    3.7 Date of Enter into Metabolic Disorders Treatment Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Metabolic Disorders Treatment Breakdown Data by Type
    4.1 Global Metabolic Disorders Treatment Historic Market Size by Type (2017-2022)
    4.2 Global Metabolic Disorders Treatment Forecasted Market Size by Type (2023-2028)
5 Metabolic Disorders Treatment Breakdown Data by Application
    5.1 Global Metabolic Disorders Treatment Historic Market Size by Application (2017-2022)
    5.2 Global Metabolic Disorders Treatment Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Metabolic Disorders Treatment Market Size (2017-2028)
    6.2 North America Metabolic Disorders Treatment Market Size by Country (2017-2022)
    6.3 North America Metabolic Disorders Treatment Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Metabolic Disorders Treatment Market Size (2017-2028)
    7.2 Europe Metabolic Disorders Treatment Market Size by Country (2017-2022)
    7.3 Europe Metabolic Disorders Treatment Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Metabolic Disorders Treatment Market Size (2017-2028)
    8.2 Asia-Pacific Metabolic Disorders Treatment Market Size by Country (2017-2022)
    8.3 Asia-Pacific Metabolic Disorders Treatment Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Metabolic Disorders Treatment Market Size (2017-2028)
    9.2 Latin America Metabolic Disorders Treatment Market Size by Country (2017-2022)
    9.3 Latin America Metabolic Disorders Treatment Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Metabolic Disorders Treatment Market Size (2017-2028)
    10.2 Middle East & Africa Metabolic Disorders Treatment Market Size by Country (2017-2022)
    10.3 Middle East & Africa Metabolic Disorders Treatment Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Merck
        11.1.1 Merck Company Detail
        11.1.2 Merck Business Overview
        11.1.3 Merck Metabolic Disorders Treatment Introduction
        11.1.4 Merck Revenue in Metabolic Disorders Treatment Business (2017-2022)
        11.1.5 Merck Recent Development
    11.2 Novartis
        11.2.1 Novartis Company Detail
        11.2.2 Novartis Business Overview
        11.2.3 Novartis Metabolic Disorders Treatment Introduction
        11.2.4 Novartis Revenue in Metabolic Disorders Treatment Business (2017-2022)
        11.2.5 Novartis Recent Development
    11.3 Takeda Pharmaceutical
        11.3.1 Takeda Pharmaceutical Company Detail
        11.3.2 Takeda Pharmaceutical Business Overview
        11.3.3 Takeda Pharmaceutical Metabolic Disorders Treatment Introduction
        11.3.4 Takeda Pharmaceutical Revenue in Metabolic Disorders Treatment Business (2017-2022)
        11.3.5 Takeda Pharmaceutical Recent Development
    11.4 Astra Zeneca
        11.4.1 Astra Zeneca Company Detail
        11.4.2 Astra Zeneca Business Overview
        11.4.3 Astra Zeneca Metabolic Disorders Treatment Introduction
        11.4.4 Astra Zeneca Revenue in Metabolic Disorders Treatment Business (2017-2022)
        11.4.5 Astra Zeneca Recent Development
    11.5 Boehringer Ingelheim
        11.5.1 Boehringer Ingelheim Company Detail
        11.5.2 Boehringer Ingelheim Business Overview
        11.5.3 Boehringer Ingelheim Metabolic Disorders Treatment Introduction
        11.5.4 Boehringer Ingelheim Revenue in Metabolic Disorders Treatment Business (2017-2022)
        11.5.5 Boehringer Ingelheim Recent Development
    11.6 KOWA
        11.6.1 KOWA Company Detail
        11.6.2 KOWA Business Overview
        11.6.3 KOWA Metabolic Disorders Treatment Introduction
        11.6.4 KOWA Revenue in Metabolic Disorders Treatment Business (2017-2022)
        11.6.5 KOWA Recent Development
    11.7 Kythera
        11.7.1 Kythera Company Detail
        11.7.2 Kythera Business Overview
        11.7.3 Kythera Metabolic Disorders Treatment Introduction
        11.7.4 Kythera Revenue in Metabolic Disorders Treatment Business (2017-2022)
        11.7.5 Kythera Recent Development
    11.8 Fuji yakuhin
        11.8.1 Fuji yakuhin Company Detail
        11.8.2 Fuji yakuhin Business Overview
        11.8.3 Fuji yakuhin Metabolic Disorders Treatment Introduction
        11.8.4 Fuji yakuhin Revenue in Metabolic Disorders Treatment Business (2017-2022)
        11.8.5 Fuji yakuhin Recent Development
    11.9 LG Life Science
        11.9.1 LG Life Science Company Detail
        11.9.2 LG Life Science Business Overview
        11.9.3 LG Life Science Metabolic Disorders Treatment Introduction
        11.9.4 LG Life Science Revenue in Metabolic Disorders Treatment Business (2017-2022)
        11.9.5 LG Life Science Recent Development
    11.10 Metsubishi Tanabe Pharma
        11.10.1 Metsubishi Tanabe Pharma Company Detail
        11.10.2 Metsubishi Tanabe Pharma Business Overview
        11.10.3 Metsubishi Tanabe Pharma Metabolic Disorders Treatment Introduction
        11.10.4 Metsubishi Tanabe Pharma Revenue in Metabolic Disorders Treatment Business (2017-2022)
        11.10.5 Metsubishi Tanabe Pharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Metabolic Disorders Treatment Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Glycogen Metabolism Disease Drug
    Table 3. Key Players of Lipid Metabolism Disease Drug
    Table 4. Key Players of Amino Acid Metabolism Drug
    Table 5. Key Players of Other
    Table 6. Global Metabolic Disorders Treatment Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 7. Global Metabolic Disorders Treatment Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 8. Global Metabolic Disorders Treatment Market Size by Region (2017-2022) & (US$ Million)
    Table 9. Global Metabolic Disorders Treatment Market Share by Region (2017-2022)
    Table 10. Global Metabolic Disorders Treatment Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 11. Global Metabolic Disorders Treatment Market Share by Region (2023-2028)
    Table 12. Metabolic Disorders Treatment Market Trends
    Table 13. Metabolic Disorders Treatment Market Drivers
    Table 14. Metabolic Disorders Treatment Market Challenges
    Table 15. Metabolic Disorders Treatment Market Restraints
    Table 16. Global Metabolic Disorders Treatment Revenue by Players (2017-2022) & (US$ Million)
    Table 17. Global Metabolic Disorders Treatment Market Share by Players (2017-2022)
    Table 18. Global Top Metabolic Disorders Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Metabolic Disorders Treatment as of 2021)
    Table 19. Ranking of Global Top Metabolic Disorders Treatment Companies by Revenue (US$ Million) in 2021
    Table 20. Global 5 Largest Players Market Share by Metabolic Disorders Treatment Revenue (CR5 and HHI) & (2017-2022)
    Table 21. Key Players Headquarters and Area Served
    Table 22. Key Players Metabolic Disorders Treatment Product Solution and Service
    Table 23. Date of Enter into Metabolic Disorders Treatment Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Metabolic Disorders Treatment Market Size by Type (2017-2022) & (US$ Million)
    Table 26. Global Metabolic Disorders Treatment Revenue Market Share by Type (2017-2022)
    Table 27. Global Metabolic Disorders Treatment Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 28. Global Metabolic Disorders Treatment Revenue Market Share by Type (2023-2028)
    Table 29. Global Metabolic Disorders Treatment Market Size by Application (2017-2022) & (US$ Million)
    Table 30. Global Metabolic Disorders Treatment Revenue Market Share by Application (2017-2022)
    Table 31. Global Metabolic Disorders Treatment Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 32. Global Metabolic Disorders Treatment Revenue Market Share by Application (2023-2028)
    Table 33. North America Metabolic Disorders Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 34. North America Metabolic Disorders Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 35. Europe Metabolic Disorders Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 36. Europe Metabolic Disorders Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 37. Asia-Pacific Metabolic Disorders Treatment Market Size by Region (2017-2022) & (US$ Million)
    Table 38. Asia-Pacific Metabolic Disorders Treatment Market Size by Region (2023-2028) & (US$ Million)
    Table 39. Latin America Metabolic Disorders Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 40. Latin America Metabolic Disorders Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 41. Middle East & Africa Metabolic Disorders Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 42. Middle East & Africa Metabolic Disorders Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 43. Merck Company Detail
    Table 44. Merck Business Overview
    Table 45. Merck Metabolic Disorders Treatment Product
    Table 46. Merck Revenue in Metabolic Disorders Treatment Business (2017-2022) & (US$ Million)
    Table 47. Merck Recent Development
    Table 48. Novartis Company Detail
    Table 49. Novartis Business Overview
    Table 50. Novartis Metabolic Disorders Treatment Product
    Table 51. Novartis Revenue in Metabolic Disorders Treatment Business (2017-2022) & (US$ Million)
    Table 52. Novartis Recent Development
    Table 53. Takeda Pharmaceutical Company Detail
    Table 54. Takeda Pharmaceutical Business Overview
    Table 55. Takeda Pharmaceutical Metabolic Disorders Treatment Product
    Table 56. Takeda Pharmaceutical Revenue in Metabolic Disorders Treatment Business (2017-2022) & (US$ Million)
    Table 57. Takeda Pharmaceutical Recent Development
    Table 58. Astra Zeneca Company Detail
    Table 59. Astra Zeneca Business Overview
    Table 60. Astra Zeneca Metabolic Disorders Treatment Product
    Table 61. Astra Zeneca Revenue in Metabolic Disorders Treatment Business (2017-2022) & (US$ Million)
    Table 62. Astra Zeneca Recent Development
    Table 63. Boehringer Ingelheim Company Detail
    Table 64. Boehringer Ingelheim Business Overview
    Table 65. Boehringer Ingelheim Metabolic Disorders Treatment Product
    Table 66. Boehringer Ingelheim Revenue in Metabolic Disorders Treatment Business (2017-2022) & (US$ Million)
    Table 67. Boehringer Ingelheim Recent Development
    Table 68. KOWA Company Detail
    Table 69. KOWA Business Overview
    Table 70. KOWA Metabolic Disorders Treatment Product
    Table 71. KOWA Revenue in Metabolic Disorders Treatment Business (2017-2022) & (US$ Million)
    Table 72. KOWA Recent Development
    Table 73. Kythera Company Detail
    Table 74. Kythera Business Overview
    Table 75. Kythera Metabolic Disorders Treatment Product
    Table 76. Kythera Revenue in Metabolic Disorders Treatment Business (2017-2022) & (US$ Million)
    Table 77. Kythera Recent Development
    Table 78. Fuji yakuhin Company Detail
    Table 79. Fuji yakuhin Business Overview
    Table 80. Fuji yakuhin Metabolic Disorders Treatment Product
    Table 81. Fuji yakuhin Revenue in Metabolic Disorders Treatment Business (2017-2022) & (US$ Million)
    Table 82. Fuji yakuhin Recent Development
    Table 83. LG Life Science Company Detail
    Table 84. LG Life Science Business Overview
    Table 85. LG Life Science Metabolic Disorders Treatment Product
    Table 86. LG Life Science Revenue in Metabolic Disorders Treatment Business (2017-2022) & (US$ Million)
    Table 87. LG Life Science Recent Development
    Table 88. Metsubishi Tanabe Pharma Company Detail
    Table 89. Metsubishi Tanabe Pharma Business Overview
    Table 90. Metsubishi Tanabe Pharma Metabolic Disorders Treatment Product
    Table 91. Metsubishi Tanabe Pharma Revenue in Metabolic Disorders Treatment Business (2017-2022) & (US$ Million)
    Table 92. Metsubishi Tanabe Pharma Recent Development
    Table 93. Research Programs/Design for This Report
    Table 94. Key Data Information from Secondary Sources
    Table 95. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Metabolic Disorders Treatment Market Share by Type: 2021 VS 2028
    Figure 2. Glycogen Metabolism Disease Drug Features
    Figure 3. Lipid Metabolism Disease Drug Features
    Figure 4. Amino Acid Metabolism Drug Features
    Figure 5. Other Features
    Figure 6. Global Metabolic Disorders Treatment Market Share by Application in 2021 & 2028
    Figure 7. Hospital Case Studies
    Figure 8. Retail Pharmacy Case Studies
    Figure 9. Metabolic Disorders Treatment Report Years Considered
    Figure 10. Global Metabolic Disorders Treatment Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 11. Global Metabolic Disorders Treatment Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 12. Global Metabolic Disorders Treatment Market Share by Region: 2021 VS 2028
    Figure 13. Global Metabolic Disorders Treatment Market Share by Players in 2021
    Figure 14. Global Top Metabolic Disorders Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Metabolic Disorders Treatment as of 2021)
    Figure 15. The Top 10 and 5 Players Market Share by Metabolic Disorders Treatment Revenue in 2021
    Figure 16. North America Metabolic Disorders Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 17. North America Metabolic Disorders Treatment Market Share by Country (2017-2028)
    Figure 18. United States Metabolic Disorders Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 19. Canada Metabolic Disorders Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Europe Metabolic Disorders Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Europe Metabolic Disorders Treatment Market Share by Country (2017-2028)
    Figure 22. Germany Metabolic Disorders Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. France Metabolic Disorders Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. U.K. Metabolic Disorders Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. Italy Metabolic Disorders Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Russia Metabolic Disorders Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Nordic Countries Metabolic Disorders Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Asia-Pacific Metabolic Disorders Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Asia-Pacific Metabolic Disorders Treatment Market Share by Region (2017-2028)
    Figure 30. China Metabolic Disorders Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Japan Metabolic Disorders Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. South Korea Metabolic Disorders Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Southeast Asia Metabolic Disorders Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. India Metabolic Disorders Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Australia Metabolic Disorders Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Latin America Metabolic Disorders Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Latin America Metabolic Disorders Treatment Market Share by Country (2017-2028)
    Figure 38. Mexico Metabolic Disorders Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Brazil Metabolic Disorders Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Middle East & Africa Metabolic Disorders Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Middle East & Africa Metabolic Disorders Treatment Market Share by Country (2017-2028)
    Figure 42. Turkey Metabolic Disorders Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Saudi Arabia Metabolic Disorders Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. Merck Revenue Growth Rate in Metabolic Disorders Treatment Business (2017-2022)
    Figure 45. Novartis Revenue Growth Rate in Metabolic Disorders Treatment Business (2017-2022)
    Figure 46. Takeda Pharmaceutical Revenue Growth Rate in Metabolic Disorders Treatment Business (2017-2022)
    Figure 47. Astra Zeneca Revenue Growth Rate in Metabolic Disorders Treatment Business (2017-2022)
    Figure 48. Boehringer Ingelheim Revenue Growth Rate in Metabolic Disorders Treatment Business (2017-2022)
    Figure 49. KOWA Revenue Growth Rate in Metabolic Disorders Treatment Business (2017-2022)
    Figure 50. Kythera Revenue Growth Rate in Metabolic Disorders Treatment Business (2017-2022)
    Figure 51. Fuji yakuhin Revenue Growth Rate in Metabolic Disorders Treatment Business (2017-2022)
    Figure 52. LG Life Science Revenue Growth Rate in Metabolic Disorders Treatment Business (2017-2022)
    Figure 53. Metsubishi Tanabe Pharma Revenue Growth Rate in Metabolic Disorders Treatment Business (2017-2022)
    Figure 54. Bottom-up and Top-down Approaches for This Report
    Figure 55. Data Triangulation
    Figure 56. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Merck
Novartis
Takeda Pharmaceutical
Astra Zeneca
Boehringer Ingelheim
KOWA
Kythera
Fuji yakuhin
LG Life Science
Metsubishi Tanabe Pharma
Frequently Asked Questions
Metabolic Disorders Treatment report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Metabolic Disorders Treatment report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Metabolic Disorders Treatment report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports